中国人のBVSYS患者におけるMED25遺伝子の新化合物ヘテロジゴス変異の病原性作用を解明
Linbing Zou1, Ruikang Qiu2, Zhijun Dai1
1Hefei Maternal and Child Health Hospital Reproductive Medicine Center, Hefei, China.
Frontiers in genetics
|September 5, 2025
まとめ
MED25遺伝子における複合性ヘテロジゴス変異は,mRNA前スプライシングを損なうことで,バゼル・ヴァナガイト・スミリン・ヨセフ症候群 (BVSYS) を引き起こします. この研究は,MED25に関連した知的障害と発達障害の背後にある分子メカニズムを明らかにしています.
科学分野:
- 分子生物学
- 遺伝学
- 医学 遺伝学
背景:
- RNAポリメラーゼII転写サブユニット25 (MED25) のメディエーターは,ほとんどの遺伝子の転写に不可欠です.
- MED25遺伝子変異は,バゼル・ヴァナガイト・スミリン・ヨセフ症候群 (BVSYS) と知的障害 (ID) のような遺伝的症候群と関連しています.
研究 の 目的:
- BVSYSを引き起こす化合物ヘテロジゴスMED25変異の分子メカニズムを解明する.
- 特定のMED25変種がmRNA前スプライシングとタンパク質構造に与える影響を調査する.
主な方法:
- 変種識別のための全エクソームシーケンシング (WES) とサンガーシーケンシング.
- スプライシングとタンパク質構造の予測のためのバイオ情報分析.
- ミニゲンスプライシングアッセイとRT-PCRをインビトロで機能的特徴づけに用いる.
主要な成果:
- MED25における複合性ヘテロジゴス変異 (c.670C>G [p.R224G] と c.1965+1dup) は,BVSYSによる試験試験で確認された.
- c.1965+1dup変異は,MED25のプレ- mRNAスプライシングを妨害することが示された.
- c.670C>G (p.R224G) 変異は,MED25タンパク質の構造を変化させ,遺伝子の機能に影響を与える可能性があります.
結論:
- 特定されたMED25変異は病原性または病原性可能性が高い.
- これらの変異は,知的障害と小頭症を含むBVSYSの臨床表型と関連しています.
- この研究は,MED25に関連する発達障害の分子基礎を明らかにしています.
関連する概念動画
Single Nucleotide Polymorphisms-SNPs
15.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.8K
Mutations in Microorganisms
74
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
74
Exon Recombination
3.7K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...
Exon shuffling follows “splice frame rules.” Each exon...
3.7K
Viral Mutations
32.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.8K
Cystic Fibrosis: Pathogenesis
358
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
358


